Trade with Eva: Analytics in action >>
Showing posts with label SYK. Show all posts
Showing posts with label SYK. Show all posts

Tuesday, January 29, 2019

-=Stryker (SYK) reported earnings on Tue 29 Jan 2019 (a/h)



KALAMAZOO, Mich. (AP) _ Stryker Corp. (SYK) on Tuesday reported fourth-quarter net income of $2.07 billion, after reporting a loss in the same period a year earlier.
The Kalamazoo, Michigan-based company said it had net income of $5.44 per share. Earnings, adjusted for non-recurring gains, were $2.18 per share.
The results beat Wall Street expectations. The average estimate of 13 analysts surveyed by Zacks Investment Research was for earnings of $2.15 per share.
The medical device maker posted revenue of $3.8 billion in the period, which also topped Street forecasts. Twelve analysts surveyed by Zacks expected $3.73 billion.
For the year, the company reported profit of $3.55 billion, or $9.34 per share. Revenue was reported as $13.6 billion.
For the current quarter ending in April, Stryker expects its per-share earnings to range from $1.80 to $1.85. Analysts surveyed by Zacks had forecast adjusted earnings per share of $1.84.
The company expects full-year earnings in the range of $8 to $8.20 per share.
Stryker shares have risen nearly 3 percent since the beginning of the year, while the Standard & Poor's 500 index has increased slightly more than 5 percent. In the final minutes of trading on Tuesday, shares hit $161.07, a decrease of almost 5 percent in the last 12 months.

Monday, January 28, 2019

Earnings this week : Jan 28 - Feb. 1, 19 (wk 5)

So far, 22% of the S&P 500 has reported quarterly results.
  • A myriad of large/mega cap bellwethers will report quarterly results next week, including Caterpillar on Monday morning and four of the largest technology companies in the world: Apple on Tuesday afternoon, Microsoft and Facebook on Wednesday and Amazon on Thursday.
Earnings confirmed to report this week:

Monday (Jan 28) 
  • Morning: BOH CAT
  • Afternoon:  AKS BRO CE CR ELS ETH GGG HTLF IBTX JJSF RGA RMBS SANM SSB WHR WSBC WWD
Mon pm/Tue am
https://finviz.com/screener.ashx?v=211&ta=0&o=-volume&t=AKS,BRO,CE,CR,ELS,ETH,GGG,HTLF,IBTX,JJSF,RGA,RMBS,SANM,SSB,WHR,WSBC,WWD,AGN,ALV,AOS,AXE,BIIB,CIT,CVLT,DHR,DOV,EAT,EXP,EXTR,FBP,GLW,GPK,HCA,HOG,HRS,KNX,LLL,LMT,MMM,MTOR,NUE,PCAR,PFE,PHG,PHM,PII,PNR,POL,PPBI,ROK,SAP,UMC,VZ,XRX

Tuesday (Jan 29)
  • Morning:  AGN ALV AOS AXE BIIB CIT CVLT DHR DOV EAT EXP EXTR FBP GLW GPK HCA HOG HRS KNX LLL LMT MMM MTOR NUE PCAR PFE PHG PHM PII PNR POL PPBI ROK SAP UMC VZ XRX
  • Afternoon: AAPL ALGN AMD AMGN AX BXP CHRW CNI COHR EBAY ILMN JNPR KLAC MSTR MXIM NATI PFG PKG RHI RNR SIMO SLGN SYK TSS UMBF WRB
Tue pm/Wed am : https://finviz.com/screener.ashx?v=211&ta=0&o=-volume&t=AAPL,ALGN,AMD,AMGN,AX,BXP,CHRW,CNI,COHR,EBAY,ILMN,JNPR,KLAC,MXIM,NATI,PFG,PKG,RHI,RNR,SIMO,SLGN,SYK,TSS,UMBF,WRB,,ADP,ALLY,ANTM,AVY,AXTA,BA,BABA,BEN,CHKP,EVR,GD,HES,IR,IVZ,MCD,NDAQ,OSK,PB,RCL,SC,SIRI,SLAB,SMG,T,TCF,TMO,TUP
Wednesday (Jan 30)
  • Morning: ADP ALLY ANTM AVY AXTA BA BABA BEN CHKP EVR GD HES IBN  IR IVZ MCD NDAQ OSK PB RCL SC SIRI SLAB SMG T TCF TMO TUP
  • Afternoon:  AFG AGNC ALGT AMP ARCB AXS BDN CACC CACI CLB CMPR CREE CRUS DLB DRE EFII EGOV ESS EZPW FB FICO FLEX GHL HOLX ISBC LLNW LSTR MAA MDLZ MEOH MLNX MSFT MTH MUR MUSA NOW PYPL QCOM RXN SEIC SXI THG TSLA TTEK V WYNN  X
Wed pm/Thur am : https://finviz.com/screener.ashx?v=211&ta=0&o=-volume&t=AFG,AGNC,ALGT,AMP,ARCB,AXS,BDN,CACC,CACI,CLB,CMPR,CREE,CRUS,DLB,DRE,EFII,EGOV,ESS,EZPW,FB,FICO,FLEX,GHL,HOLX,ISBC,LLNW,LSTR,MAA,MDLZ,MEOH,MLNX,MSFT,MTH,MUR,MUSA,NOW,PYPL,QCOM,RXN,SEIC,SXI,THG,TSLA,TTEK,V,WYNN,X,ABC,ABMD,APO,APRN,APTV,BAX,BC,BHGE,BLL,BMS,BX,CELG,CFR,CHTR,CMCO,CMS,CNX,CNXM,COP,CRR,CRS,DWDP,EPD,ETN,FCFS,FLWS,GE,HSY,IIVI,IP,KEM,KEX,KIM,LANC,MA,MAN,MDC,MIXT,MMC,MMP,MNRO,MO,MSCI,NOC,NOK,NS,NVT,OMN,PH,RACE,RDS-A,RFP,RTN,S,SHW,SILC,SNDR,TSCO,UPS,VLO,VLY,WCC,WRK,WRLD,XEL,XYL,YRCW

Thursday (Jan 31)
  • Morning:  ABC ABMD APO APRN APTV BAX BC BHGE BLL BMS BX CELG CFR CHTR CMCO CMS CNX CNXM COP CRR CRS DWDP EPD ETN FCFS FLWS GE HSY IIVI IP KEM KEX KIM LANC MA MAN MDC MIXT MMC MMP MNRO MO MSCI NOC NOK NS NVT OMN PH RACE RDS.A RFP RTN S SHW SILC SNDR TSCO UPS VLO VLY WCC WRK WRLD XEL XYL YRCW
  • Afternoon:  AFL AJG AMZN CLS CPT CY DECK EMN ENVA EPAY ESL EW EXPO FBHS HAYN KLIC LPLA MATW MCK MOD MTX NFG OTEX PFPT PKI POST SIGI SKYW SYMC WAIR YUMC
 Thur pm/Fri am : https://finviz.com/screener.ashx?v=211&ta=0&o=-volume&t=AFL,AJG,AMZN,CLS,CPT,CY,DECK,EMN,ENVA,EPAY,ESL,EW,EXPO,FBHS,HAYN,KLIC,LPLA,MATW,MCK,MOD,MTX,NFG,OTEX,PFPT,PKI,POST,SIGI,SKYW,SYMC,WAIR,YUMC,AON,BAH,BERY,CI,CVX,CYOU,D,HMC,HON,IDXX,IMO,ITW,JCI,KKR,LYB,MINI,MRK,MSG,OSB,PFS,ROP,SBSI,SF,SNE,SOGO,SOHU,SPG,SPR,VRTS,WETF,WFT,WY,XOM,ZBH

Friday (Feb 1)
  • Morning: AON BAH BERY CI CVX CYOU D HMC HON IDXX IMO ITW JCI KKR LYB MINI MRK MSG OSB PFS ROP SBSI SF SNE SOGO SOHU SPG SPR VRTS WETF WFT WY XOM ZBH

According to FactSet, fourth quarter reported earnings per share are up 12% with sales up 6.6%. Fourth quarter earnings are now expected to grow 11% with sales up 6.0%. Roughly 67% have exceeded earnings estimates while 55% have beaten revenue expectations. 59% of companies reporting earnings have traded higher in response.

First quarter EPS are now expected to grow just 0.5% with sales up 6%. For 2019, earnings are expected to grow 6.1% with sales up 5.3%.

Monday, June 11, 2018

-=Boston Scientific(BSX) : report of buyout approach from Stryker (SYK)


  • The Wall Street Journal reported that the medical device company received a buyout approach medical technology products company Stryker Corp. (SYK)
  • That would create a medical-device giant with a combined value of more than $110 billion.

Thursday, October 26, 2017

-=Stryker (SYK) reported earnings on Thur 26 Oct 2017 (a/h)



Stryker beats by $0.02, beats on revs; guides Q4 EPS in-line
  • Reports Q3 (Sep) earnings of $1.52 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus of $1.50; revenues rose 6.1% year/year to $3.01 bln vs the $2.97 bln Capital IQ Consensus.
  • Co issues in-line guidance for Q4, sees EPS of $1.92-1.97, excluding non-recurring items, vs. $1.93 Capital IQ Consensus Estimate; continues to expect 2017 organic net sales growth to be in the range of 6.5% to 7.0%.